Thrombin Preconditioning of Extracellular Vesicles Derived from Mesenchymal Stem Cells Accelerates Cutaneous Wound Healing by Boosting Their Biogenesis and Enriching Cargo Content

Overview

Journal J Clin Med

Specialty General Medicine

Date 2019 Apr 21

PMID 31003433

Citations 34

Authors

Dong Kyung Sung

Yun Sil Chang

Se In Sung

So Yoon Ahn

Won Soon Park

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the optimal preconditioning regimen for the wound healing therapeutic efficacy of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs). To this end, we compared various preconditioning regimens for both the quantitative and qualitative production of MSC-derived EVs, and their therapeutic efficacy for proangiogenic activity in vitro and cutaneous wound healing in vivo. After preconditioning with thrombin (40 U), HO (50 μM), lipopolysaccharide (1 μg/mL), or hypoxia (10% O), EV secretion was assessed quantitatively by measuring production per cell and protein quantification, and qualitatively by measuring a proteome profiler and an enzyme-linked immunosorbent assay (ELISA) contained within EVs. The therapeutic efficacy of EVs was assessed in vitro by proliferation, migration and tube formation assays of human umbilical cord blood endothelial cells (HUVECs), and in vivo by quantification of cutaneous wound healing. Thrombin preconditioning optimally boosted EV production and enriched various growth factors including vascular endothelial growth factor and angiogenin contained within EVs compared to other preconditioning regimens. Thrombin preconditioning optimally enhanced proliferation, the migration and tube formation of HUVECs in vitro via ERK1/2 and AKT signaling pathways, and cutaneous wound healing in vivo compared to other preconditioning regimens. Thrombin preconditioning exhibited optimal therapeutic efficacy compared with other preconditioning regimens in promoting proangiogenic activity in vitro and in enhancing cutaneous wound healing in vivo. These preconditioning regimen-dependent variations in therapeutic efficacy might be mediated by boosting EV production and enriching their cargo content.

Citing Articles

Thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles attenuate experimental necrotizing enterocolitis.

Hwang S, Sung S, Kim Y, Yang M, Koh A, Ahn S Stem Cell Res Ther. 2025; 16(1):101.

PMID: 40022236 PMC: 11871789. DOI: 10.1186/s13287-025-04243-3.

Diagnosis and surgical decision-making of a 46, XX ovotesticular disorders of sex development patient: a case report.

Zhao H, Chen Z, Wang B, Zhang Z, Li Z Front Surg. 2024; 11:1502340.

PMID: 39723339 PMC: 11668777. DOI: 10.3389/fsurg.2024.1502340.

Efficient Treatment of Psoriasis Using Conditioned Media from Mesenchymal Stem Cell Spheroids Cultured to Produce Transforming Growth Factor-1-Enriched Small-Sized Extracellular Vesicles.

Song M, Lim K, Song K, Kang G, Kim S, Lee Y Int J Stem Cells. 2024; 17(4):407-417.

PMID: 39396918 PMC: 11612221. DOI: 10.15283/ijsc24089.

Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders.

Chang Y, Yang M, Ahn S, Sung S, Park W Stem Cells Transl Med. 2024; 13(10):941-948.

PMID: 39120439 PMC: 11465171. DOI: 10.1093/stcltm/szae060.

Therapeutic efficacy of thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles on Escherichia coli-induced acute lung injury in mice.

Bang Y, Hwang S, Kim Y, Sung D, Yang M, Ahn S Respir Res. 2024; 25(1):303.

PMID: 39112999 PMC: 11308396. DOI: 10.1186/s12931-024-02908-w.

References

Tsopanoglou N, Maragoudakis M . On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem. 1999; 274(34):23969-76. DOI: 10.1074/jbc.274.34.23969. View

Heijnen H, Schiel A, Fijnheer R, Geuze H, Sixma J . Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999; 94(11):3791-9. View

Savina A, Furlan M, Vidal M, Colombo M . Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem. 2003; 278(22):20083-90. DOI: 10.1074/jbc.M301642200. View

Soares R, Balogh G, Guo S, Gartner F, Russo J, Schmitt F . Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol. 2004; 18(9):2333-43. DOI: 10.1210/me.2003-0362. View

Etscheid M, Beer N, Dodt J . The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. Cell Signal. 2005; 17(12):1486-94. DOI: 10.1016/j.cellsig.2005.03.007. View

Boulton A, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J . The global burden of diabetic foot disease. Lancet. 2005; 366(9498):1719-24. DOI: 10.1016/S0140-6736(05)67698-2. View

Jang Y, Jung D, Jung M, Kim D, Yoo K, Sung K . Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol. 2006; 85(4):212-25. DOI: 10.1007/s00277-005-0047-3. View

Cha J, Falanga V . Stem cells in cutaneous wound healing. Clin Dermatol. 2007; 25(1):73-8. DOI: 10.1016/j.clindermatol.2006.10.002. View

Lee J, Lee M, Jin H, Kim D, Yang Y, Oh W . Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides. Cell Transplant. 2007; 16(8):849-57. DOI: 10.3727/000000007783465271. View

10.

Branski L, Gauglitz G, Herndon D, Jeschke M . A review of gene and stem cell therapy in cutaneous wound healing. Burns. 2008; 35(2):171-80. PMC: 3899575. DOI: 10.1016/j.burns.2008.03.009. View

11.

Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine J . Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008; 15(11):1723-33. DOI: 10.1038/cdd.2008.104. View

12.

Morello F, Perino A, Hirsch E . Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res. 2008; 82(2):261-71. DOI: 10.1093/cvr/cvn325. View

13.

Chang Y, Oh W, Choi S, Sung D, Kim S, Choi E . Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 2009; 18(8):869-86. DOI: 10.3727/096368909X471189. View

14.

Park J, Tan H, Datta A, Lai R, Zhang H, Meng W . Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010; 9(6):1085-99. PMC: 2877972. DOI: 10.1074/mcp.M900381-MCP200. View

15.

Sellheyer K, Krahl D . [Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications]. Hautarzt. 2010; 61(5):429-34. DOI: 10.1007/s00105-010-1919-6. View

16.

Kim J, Kim D, Kim D, Kim J, Jeong S, Jeon H . Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro. FEBS Lett. 2010; 584(16):3601-8. DOI: 10.1016/j.febslet.2010.07.028. View

17.

Heng M . Wound healing in adult skin: aiming for perfect regeneration. Int J Dermatol. 2011; 50(9):1058-66. DOI: 10.1111/j.1365-4632.2011.04940.x. View

18.

Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X . Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012; 30(7):1556-64. PMC: 3495063. DOI: 10.1002/stem.1129. View

19.

Baglio S, Pegtel D, Baldini N . Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol. 2012; 3:359. PMC: 3434369. DOI: 10.3389/fphys.2012.00359. View

20.

Liang X, Ding Y, Zhang Y, Tse H, Lian Q . Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2013; 23(9):1045-59. DOI: 10.3727/096368913X667709. View